Hyperthermophilic Microorganisms and USP Hot Water Systems

Author(s)Jos&#233 E. Mart&#237nez, MS, MT, José E. Martinez

The author discusses why two of the industry's common practices for preventing microorganism contamination in USP hot-ware and purified-water systems may have no scientific basis.

External Link - article-84559.pdf

Articles in this issue

over 22 years ago

Article

Big Pharma Works on Productivity

over 22 years ago

Article

Electronic Information Systems

over 22 years ago

Article

CMO-grown Innovation and Technology

over 22 years ago

Article

Segregation of Powders during Gravity Flow Through Vertical Pipes

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related to this article

Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.

October 21st, 2026

Nitrosamine Problems and Industry Solutions: PharmTech Explained

Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.

OpenAI acquires Orchestra Bio, adding AI agents for drug program coordination to its Rosalind suite.

October 20th, 2026

OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio

OpenAI acquired Orchestra Bio to pair AI agents that track drug development timelines with its Rosalind life sciences tools, raising oversight questions for pharma teams.

October 20th, 2026

AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing

Ravi Kiran Kaja, PhD, explains how USP’s industry-wide initiative aims to build confidence in trace-level extractables and leachables results.

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

October 20th, 2026

Drug-Device Combination Apps: The FDA's 3 Questions for Sponsors

FDA final guidance defines when companion app output counts as drug labeling and when device-connected or standalone apps belong in prescribing information.

Recyclable blisters, EU PPWR rules, and digital patient leaflets are reshaping drug packaging today.

October 20th, 2026

Sustainability in Healthcare Packaging: The Journey From Yesterday to Tomorrow

Science, circularity, regulation, and technology are reshaping how the industry develops packaging for medicines.

October 19th, 2026

PharmTech AI Pulse Check: SURPASS and the Case for Simulation-Based Trials

Panelists on PharmTech AI Pulse Check debate SURPASS, a new digital-twin trial program, regulatory acceptance, and the data-cleanup burden it will create.